Perrigo Approved For Allergy Med
ALLEGAN — Perrigo Co. has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter Children’s Cetirizine Hydrochloride Oral Solution for indoor and outdoor allergy and hives relief.
The product, which is comparable to McNeil Consumer Healthcare’s Children’s Zyrtec Oral Solution, will be marketed under store brand labels. Brand sales for the original prescription-strength version for the 12 months ending December 2007 were approximately $80 million. Perrigo expects to begin shipping the product immediately.
“This approval reflects our strategy to be first to market with the important products that make quality health care more affordable for our customers,” said Chairman and CEO Joseph C. Papa.